PT  - JOURNAL ARTICLE
AU  - Lederman, Lynne
ED  - Lee, Agnes Y. Y.
TI  - Tinzaparin Reduces the Risk of Recurrent Thromboembolic Events in Patients With Cancer
DP  - 2014  01
TA  - MD Conference Express
PG  - 12--12
VI  - 14
IP  - 55
4099  - http://mdc.sagepub.com/content/14/55/12.short
4100  - http://mdc.sagepub.com/content/14/55/12.full
AB  - In patients with active cancer and acute venous thromboembolism, tinzaparin reduced the cumulative risk of recurrent venous thromboembolism and significantly reduced the risk of symptomatic deep vein thrombosis. Full-dose tinzaparin did not increase the risk of major bleeding and was associated with a significantly decreased risk of clinically relevant nonmajor bleeding.